Element Biosciences Partners with Agilent Technologies To Validate SureSelect Target Enrichment Panels on Element’s AVITI System

Element Biosciences Inc., developer of a new and disruptive DNA sequencing platform, announced a partnership with Agilent Technologies demonstrating integration of Element’s AVITI System with Agilent Technologies’ industry-leading SureSelect target enrichment panels, providing customers greater access to these genomic tools.

Latest Aithority Insights: Yanmar Invests $21 Million in GetMyBoat as Part of Series B Funding to Drive Digital Transformation

“We are excited to collaborate with Element Biosciences in enabling the next step forward in performance and efficiency for this essential NGS technology”

Target enrichment as a pre-sequencing DNA preparation method is invaluable for clinical and industrial applications where accuracy, cost-effectiveness, and throughput are critical. As a leader in hybridization-based target enrichment, Agilent’s SureSelect sequencing panels are highly sensitive and enable detection of single-nucleotide, structural and copy number variants, fusions, insertions, and deletions.

Browse The Complete News About Aithority: How an Iconic Brand Used Digital Trust and Transparency to Enhance Analytics-driven CX

“Element’s sequencing quality, lower duplication rates, and platform flexibility seamlessly integrate with Agilent’s widely used target enrichment technology. Our partnership with Agilent has validated our AVITI system with the SureSelect hybrid-capture target enrichment solutions,” said Shawn Levy, Senior Vice President of Applications and Scientific Affairs, Element Biosciences. “This partnership will advance target enrichment and sequencing on the AVITI system to deliver exceptional value and performance to our customers.”

“We are excited to collaborate with Element Biosciences in enabling the next step forward in performance and efficiency for this essential NGS technology,” stated Kevin Meldrum, Vice President and General Manager for Agilent’s Integrated Genomics Division. “Demonstrating the successful combination of the AVITI platform with the SureSelect portfolio will help NGS users leverage our trusted and proven SureSelect solution. Our partnership will accelerate adoption of this powerful genomic analysis tool while minimizing re-design and improving lab optimization efforts.”

Read More About Aithority News : CSG Unlocks the Potential Of 5G With Launch of Future-Ready, SaaS Commerce Solution, CSG Encompass

 [To share your insights with us, please write to sghosh@martechseries.com]